Trial Condition(s):

N/A

Relative bioavailability of rivaroxaban under different administration conditions

Bayer Identifier:

17861

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

2015-000082-31

Study Completed

Trial Purpose

Inclusion Criteria
No Inclusion Criteria Available
Exclusion Criteria
No Exclusion Criteria Available

Trial Summary

Enrollment Goal
16
Trial Dates
black-arrow
Phase
1
Could I receive a placebo?
No
Products
Xarelto (Rivaroxaban, BAY59-7939)
Accepts Healthy Volunteers
Yes

Where to Participate

Loading...
Locations
Status
LocationsStatus
Locations

Investigative Site

Mannheim, Germany, 68167

Status
Completed
 

For details, please refer to trial results

Additional Information